ArticleTranslational cancer research2022

Trastuzumab in combination with chemotherapy for HER2-positive metastatic gastric cancer patients underwent conversion therapy.

Yanqiang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.